<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a boy with Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> (FA) who developed <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) (FAB-LI) followed by <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) (<z:e sem="disease" ids="C0023465" disease_type="Neoplastic Process" abbrv="">FAB-M5</z:e>) at relapse </plain></SENT>
<SENT sid="1" pm="."><plain>The patient was diagnosed with early pre-B-cell ALL without preceding <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and was treated with ALL-oriented chemotherapy which included <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> (a total dose of 140 mg/m(2) administered), which is a <z:chebi fb="0" ids="50750">topoisomerase II inhibitor</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Complete remission was obtained, but after 38 weeks <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> developed </plain></SENT>
<SENT sid="3" pm="."><plain>The karyotype of ALL cells at diagnosis showed 46,XY, and that of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cells at relapse was 46,XY, t(11;16)(q23;p13) </plain></SENT>
<SENT sid="4" pm="."><plain>An MLL gene rearrangement and MLL-CBP chimeric <z:chebi fb="2" ids="33699">mRNA</z:chebi> were found in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, but not in ALL </plain></SENT>
<SENT sid="5" pm="."><plain>A diagnosis of FA was confirmed by an increased number of chromosomal breaks and rearrangements in peripheral blood lymphocytes cultured with <z:chebi fb="0" ids="52290">mitogen</z:chebi> in the presence of <z:chebi fb="0" ids="27504">mitomycin C</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that this FA patient developed ALL followed by a therapy-related t(11;16)-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> resulting in an MLL-CBP fusion </plain></SENT>
<SENT sid="7" pm="."><plain>Further examination of such patients would shed light on <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> in FA patients </plain></SENT>
<SENT sid="8" pm="."><plain>Genes Chromosomes <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> 27:264-269, 2000 </plain></SENT>
</text></document>